• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics
 
  • Details
  • Full
Options
2023
Journal Article
Title

Potential Therapeutic Approaches for Chronic Urticaria: Beyond H1-Antihistamines and Biologics

Abstract
Chronic urticaria is a disease that can significantly impact a patient's quality of life and ability to function. There are effective treatment options, such as nonsedating antihistamines or biologics, but some patients do not respond to these therapies, or the therapies are not available or affordable to all patients. This review aims to summarize potential treatment strategies for patients (1) who do not respond to antihistamines and (2) cannot readily access or do not respond to biologics. The review emphasizes the importance of sound clinical practice, including correct diagnosis of chronic urticaria phenotypes, treatment of associated comorbidities, and consideration of add-on pharmacological and nonpharmacological approaches. Although some treatments may lack high-quality evidence, they may still be justifiable in certain cases, provided that there is shared decision-making, regular reassessment, and early recognition of adverse events.
Author(s)
Zuberbier, Torsten
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Peter, Jonathan Grant
University of Cape Town
Staubach, Petra
Universitätsmedizin Mainz
Chularojanamontri, Leena
Siriraj Hospital
Kulthanan, Kanokvalai
Siriraj Hospital
Journal
The journal of allergy and clinical immunology. In practice  
DOI
10.1016/j.jaip.2023.06.027
Language
English
Fraunhofer-Institut für Translationale Medizin und Pharmakologie ITMP  
Keyword(s)
  • Chronic urticaria

  • Current management

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024